Pharma-Bio Serv (PBSV) News Today → Don’t buy Gold until you see this (From The TradingPub) (Ad) Free PBSV Stock Alerts $0.70 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 23, 2024 | americanbankingnews.comPharma-Bio Serv (OTCMKTS:PBSV) Stock Passes Below 200 Day Moving Average of $0.89May 18, 2024 | wsj.comPharma-Bio Serv Inc.May 14, 2024 | msn.comKörber Pharma and Siemens Take the Lead in ABI Research's MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive RankingMay 2, 2024 | markets.businessinsider.comBBIO Stock Earnings: BridgeBio Pharma Beats EPS, Beats Revenue for Q1 2024April 25, 2024 | markets.businessinsider.comDeep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)April 25, 2024 | markets.businessinsider.comEQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché LaboratóriosApril 23, 2024 | markets.businessinsider.comBiomarin Pharmaceutical earnings preview: what Wall Street is expectingApril 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market ExpectationsApril 9, 2024 | tmcnet.comSanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com's Supplier Pre-assessment ProgramApril 3, 2024 | benzinga.comLooking Into Biomarin Pharmaceutical's Recent Short InterestMarch 19, 2024 | finance.yahoo.comPBSV Releases Quarterly ResultsMarch 19, 2024 | seekingalpha.comPharma-Bio Serv reports Q1 resultsMarch 4, 2024 | markets.businessinsider.comBuy Rating Affirmed for BridgeBio Pharma Amidst Strategic Bayer Collaboration and Promising Financial OutlookMarch 4, 2024 | markets.businessinsider.comMaintaining Hold on BridgeBio Pharma Amidst Bayer Partnership and Market UncertaintiesFebruary 26, 2024 | marketwatch.comBioMarin Pharmaceutical Gets DOJ Subpoena for Documents Related to Vimizim, Naglazyme -- UpdateFebruary 23, 2024 | markets.businessinsider.comStrong Voxzogo Performance Underpins Buy Rating for BioMarin PharmaceuticalJanuary 30, 2024 | finance.yahoo.comPBSV Expands Margins and MarketsJanuary 28, 2024 | msn.comJubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger DealJanuary 9, 2024 | markets.businessinsider.comOptimistic Outlook: Buy Rating for BridgeBio Pharma with Promising Treatment Launches and Strategic Growth DriversJanuary 8, 2024 | seekingalpha.comBridgeBio Pharma's Robust Pipeline Could Benefit From A PartnerJanuary 3, 2024 | finance.yahoo.comPBSV Reward Shareholders with High YieldDecember 21, 2023 | finanznachrichten.dePharma-Bio Serv Inc.: Pharma-Bio Serv Announces Special DividendDecember 8, 2023 | msn.comAbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?November 28, 2023 | markets.businessinsider.comBioMarin Pharma Reaches Agreement On Reimbursement Amount For ROCTAVIAN In GermanyNovember 7, 2023 | markets.businessinsider.comPromising Future for BridgeBio Pharma: Lebovitz’s Buy Rating Backed by Potential Blockbusters and Pipeline AssetsNovember 6, 2023 | markets.businessinsider.comBridgeBio Pharma Receives Buy Rating Amid Promising Drug Pipeline Developments and Strong Financial PositionSeptember 15, 2023 | finance.yahoo.comPBSV Boosts Margins and Expands MarketsSeptember 14, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023August 31, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN) and Phibro Animal Health (PAHC)July 28, 2023 | thestreet.comPharma-Bio Serv IncJuly 17, 2023 | msn.comBridgeBio Pharma: Positive ATTR-CM Treatment Data Leads To Other 2023 CatalystsJuly 15, 2023 | marketwatch.comBridgeBio Pharma Shares Rise 14% on Expected Results from Heart-Disease StudyJuly 15, 2023 | marketwatch.comStocks to Watch: BridgeBio Pharma, Universal Security Instruments, BYND Cannasoft EnterprisesJune 20, 2023 | technews.tmcnet.comPearl Bio Secures Breakthrough IP for Multi-Functionalized BiologicsJune 15, 2023 | finance.yahoo.comPBSV: A Consistent Performer with Impressive DividendJune 14, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023June 13, 2023 | ca.finance.yahoo.comTBPMF - Tetra Bio-Pharma Inc.June 10, 2023 | finance.yahoo.comPBSV - Pharma-Bio Serv, Inc.May 20, 2023 | msn.comAvid Bioservices Bolsters Manufacturing Capabilities And Generates High-Demand ServicesMay 15, 2023 | tmcnet.comBridgeBio Pharma to Present Updated Data from itsMay 10, 2023 | marketwatch.comBio Pharma Buffer Market Research | 2023-2030May 9, 2023 | marketwatch.comGlobal "Bio Pharma Logistics Market" 2023 Research Report | Enhanced Growth Size, Estimates and Regional Outlook by 2030 | Research Reports WorldApril 25, 2023 | markets.businessinsider.comHere's what Wall Street expects from Biomarin Pharmaceutical's earningsApril 20, 2023 | benzinga.comPharma-Bio Serv Stock (OTC:PBSV), Quotes and News SummaryApril 8, 2023 | marketwatch.comBio Pharma Buffer Market 2023 Size and Forecast to 2031March 20, 2023 | finance.yahoo.comPBSV: A Steady Performer with Upside PotentialMarch 17, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023March 7, 2023 | markets.businessinsider.com4 Analysts Have This to Say About BridgeBio PharmaMarch 3, 2023 | markets.businessinsider.comSVB Securities Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)February 21, 2023 | marketwatch.comBio Pharma Buffer Market 2023: Emerging Trends and Best Practices in Futurism till 2028 Get Pharma-Bio Serv News Delivered to You Automatically Sign up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Email Address AI Stocks Set to Skyrocket – Free Report Inside (Ad)Are you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket. Download our free report today PBSV Media Mentions By Week PBSV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBSV News Sentiment▼-1.000.73▲Average Business Services News Sentiment PBSV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBSV Articles This Week▼10▲PBSV Articles Average Week Get Pharma-Bio Serv News Delivered to You Automatically Sign up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TSSI News Today LICN News Today LTBR News Today ISDR News Today WHLM News Today AERT News Today CTM News Today GOPH News Today RVYL News Today ATIF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PBSV) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBiden replacement revealed?Paradigm PressThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma-Bio Serv, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
